objective overexpression of igfi occurs in tumors diagnosed in childhood osteosarcoma wilms tumor neuroblastoma etcand in adults breast ovaries colon and prostate cancerthe aim of our study was to establish the prevalence of malignancies in states of congenital igfi deficiencysubjects we surveyed 222 patients with congenital igfi deficiency laron syndrome gh gene deletion ghrh receptor defects and igfi resistance and 338 first and seconddegree relativesresults none of the igfi deficient patients had cancer whereas 924 of the family members had a history of malignancyconclusions congenital igfi deficiency acts as a protecting factor for the development of cancer